* DermTech Inc is expected to show a rise in quarterly revenue when it reports results on May 2 (estimated) for the period ending March 31 2024
* The San Diego California-based company is expected to report a 14.9% increase in revenue to $3.994 million from $3.48 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
* LSEG's mean analyst estimate for DermTech Inc is for a loss of 57 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for DermTech Inc is $1.50, above its last closing price of $0.60.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.56 -0.56 Met 0.9
Sep. 30 2023 -0.76 -0.76 -0.57 Beat 24.8
Jun. 30 2023 -0.98 -0.97 -0.99 Missed -1.7
Mar. 31 2023 -0.91 -0.91 -1.02 Missed -12.4
Dec. -0.96 -0.96 -0.93 Beat 3.4
31 2022
Sep. 30 2022 -0.93 -0.95 -0.96 Missed -0.6
Jun. 30 2022 -1.01 -1.01 -0.99 Beat 2.4
Mar. 31 2022 -0.89 -0.87 -1.01 Missed -15.7
This summary was machine generated April 30 at 11:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments